HomeOCUL • NASDAQ
add
Ocular Therapeutix Inc
Previous close
$16.11
Day range
$15.58 - $16.31
Year range
$5.79 - $16.44
Market cap
3.32B USD
Avg Volume
2.98M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 14.54M | -5.71% |
Operating expense | 29.11M | 27.63% |
Net income | -69.42M | -90.22% |
Net profit margin | -477.30 | -101.75% |
Earnings per share | -0.38 | -72.73% |
EBITDA | -67.63M | -50.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 344.77M | -19.30% |
Total assets | 410.88M | -16.21% |
Total liabilities | 152.65M | 10.34% |
Total equity | 258.23M | — |
Shares outstanding | 213.05M | — |
Price to book | 10.89 | — |
Return on assets | -39.84% | — |
Return on capital | -47.83% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -69.42M | -90.22% |
Cash from operations | -50.72M | -38.75% |
Cash from investing | -5.99M | -6,633.71% |
Cash from financing | 10.36M | 147.87% |
Net change in cash | -46.36M | -42.78% |
Free cash flow | -31.79M | -33.43% |
About
CEO
Founded
2006
Headquarters
Website
Employees
274
